What if I told you the pharma industry losing $250B in revenue wasn’t a crisis—but a success? The patent cliff is back in the headlines. I believe it’s being widely misunderstood—and that the real problem lies elsewhere.

Ireland's biopharma sector is a world-class success story, but what worked in the past will not lead to future success. We've spent...